©2026 Business Next Media Corp. All Rights Reserved. No.102, Guangfu S. Rd., Da'an Dist., Taipei City 106, Taiwan
AI Healthcare Operations Startup Nitra Raises $187M as Platform Scales Across U.S. Clinics
U.S.-based healthcare operations startup Nitra has raised $187 million in combined equity and debt financing, as the company expands its AI-powered platform designed to help medical practices manage their operations.
The funding comes as the company reports rapid growth. Nitra’s revenue grew more than 740 percent in 2025, while transaction volume on the platform surpassed $1 billion in annualized processing across more than 700 clinics and 2,500 physicians in the United States.
The round includes participation from investors across the United States, Taiwan, and South Korea, including New Enterprise Associates (NEA), Pantera Capital, Dunamu & Partners, Actions Capital, Sazze Partners, and Markham Valley Ventures, the investment fund of actor Simu Liu. Taiwan-based investors AppWorks, PIDC, and Purestone Silks also joined the round.
In addition to the equity financing, Nitra secured $20 million in venture debt from Avenue Capital Group and a $95 million warehouse financing facility from Treville Capital Group and Encina Lender Finance.
Nitra Targets Healthcare’s Fragmented Operational Infrastructure
Founded by Tim Hwang and Jonathan Chen, Nitra focuses on improving the operational infrastructure used by healthcare practices.
While much of healthcare technology has focused on clinical documentation or insurance billing, many clinics still rely on fragmented systems to manage the business side of care, including payments, procurement, scheduling, and administrative tasks.
Nitra’s platform integrates financial infrastructure, operational software, and AI automation into a single system designed to streamline these workflows.
The company initially launched financial tools such as corporate cards, payments, bill pay, and expense management, before expanding into areas including procurement, inventory management, accounting, and patient operations.
Today, the platform is used by clinics across multiple specialties, including dermatology, plastic surgery, and ophthalmology.
Procurement and Supply Chains Become a Key Growth Area
Beyond software and financial tools, Nitra has expanded into healthcare procurement through products including NitraRX and NitraMart.
The company partners with major distributors such as McKesson and Medline to offer pharmaceutical and medical supply purchasing directly within its platform.
Nitra has also obtained specialty pharmaceutical licenses that allow it to distribute certain drugs directly to healthcare providers. According to the company, this business line has already grown into a high seven-figure revenue stream and is expected to reach mid eight figures by the end of the year.
By combining procurement with financial workflows, the company aims to embed itself more deeply in the daily operations of medical practices.
AI Automation as the Long-Term Strategy
Nitra says a key part of its strategy is using operational data generated through its platform to power AI-driven automation.
Transactions processed through the system provide insight into how clinics manage purchasing, payments, staffing, and scheduling. This allows the platform to automate administrative processes and recommend operational decisions.
Over time, the company plans to deploy AI agents capable of managing tasks such as patient scheduling, insurance verification, inventory ordering, and financial reconciliation.
Nitra also maintains a growing engineering team in Taiwan, where much of the company’s product development takes place.
Looking ahead, the company aims to expand its platform to more than 3,000 clinics, targeting $4 billion in annualized transaction volume and $150 million in annual revenue by 2026.
©2026 Business Next Media Corp. All Rights Reserved. No.102, Guangfu S. Rd., Da'an Dist., Taipei City 106, Taiwan